About the IRA Program
The Inflation Reduction Act (IRA) was signed into law in 2022. It is a significant piece of legislation, with a potentially profound impact on the US health care system and drug development landscape. A sound knowledge of the technical detail of the Act is needed before we can understand what its true influence may be.
Rather than speculating on its potential impact, in this Educational Program we explain the key IRA provisions as they relate to pharmaceutical payment and coverage. We aim to promote a common factual understanding the IRA’s provisions, equipping learners with the knowledge and information needed to support informed conversation and debate on its potential impacts.